BACKGROUND AND OBJECTIVES: Malformations of cortical development (MCD), though individually rare, constitute a significant burden of disease. The diagnostic yield of next-generation sequencing (NGS) in these patients varies across studies and methods, and novel genes and variants continue to emerge. METHODS: Patients (n = 123) with a definite radiologic or histopathologic diagnosis of MCD, with or without epilepsy were included in this study. They underwent NGS-based targeted gene panel (TGP) testing, whole-exome sequencing (WES), or WES-based virtual panel testing. Selected patients who underwent epilepsy surgery (n = 69) also had somatic gene testing of brain tissue-derived DNA. We analyzed predictors of positive germline genetic finding and diagnostic yield of respective methods. RESULTS: Pathogenic or likely pathogenic germline genetic variants were detected in 21% of patients (26/123). In the surgical subgroup (69/123), we performed somatic sequencing in 40% of cases (28/69) and detected causal variants in 18% (5/28). Diagnostic yield did not differ between TGP, WES-based virtual gene panel, and open WES (p = 0.69). Diagnosis of focal cortical dysplasia type 2A, epilepsy, and intellectual disability were associated with positive results of germline testing. We report previously unpublished variants in 16/26 patients and 4 cases of MCD with likely pathogenic variants in non-MCD genes. DISCUSSION: In this study, we are reporting genetic findings of a large cohort of MCD patients with epilepsy or potentially epileptogenic MCD. We determine predictors of successful ascertainment of a genetic diagnosis in real-life setting and report novel, likely pathogenic variants in MCD and non-MCD genes alike.

Department of Paediatric Neurology 2nd Faculty of Medicine Charles University and Motol University Hospital Czech Republic

See more in PubMed

Harvey AS, Cross JH, Shinnar S, Mathern GW, Mathern BW, ILAE Pediatric Epilepsy Surgery Survey Taskforce. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia. 2008;49(1):146-155. PubMed

Blumcke I, Spreafico R, Haaker G, et al. , EEBB Consortium. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648-1656. PubMed

Lamberink HJ, Boshuisen K, van Rijen PC, Gosselaar PH, Braun KPJ, Dutch Collaborative Epilepsy Surgery Program DCESP. Changing profiles of pediatric epilepsy surgery candidates over time: a nationwide single-center experience from 1990 to 2011. Epilepsia. 2015;56(5):717-725. PubMed

Oegema R, Barakat TS, Wilke M, et al. . International consensus recommendations on the diagnostic work-up for malformations of cortical development. Nat Rev Neurol. 2020;16(11):618-635. PubMed PMC

Lee S, Kim SH, Kim B, et al. . Clinical implementation of targeted gene sequencing for malformation of cortical development. Pediatr Neurol. 2020;103:27-34. PubMed

Sim NS, Ko A, Kim WK, et al. . Precise detection of low-level somatic mutation in resected epilepsy brain tissue. Acta Neuropathol. 2019;138:901-912. PubMed

Stevelink R, Sanders MW, Tuinman MP, et al. . Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review. Epileptic Disord. 2018;20(2):99-115. PubMed

Sanders MWCB, Lemmens CMC, Jansen FE, Brilstra EH, Koeleman BPC, Braun KPJ, Dutch Collaborative Epilepsy Surgery Program LWEC. Implications of genetic diagnostics in epilepsy surgery candidates: a single-center cohort study. Epilepsia Open. 2019;4(4):609-617. PubMed PMC

Fisher RS, Acevedo C, Arzimanoglou A, et al. . ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. PubMed

Severino M, Geraldo AF, Utz N, et al. . Definitions and classification of malformations of cortical development: practical guidelines. Brain. 2020;143:2874-2894. PubMed PMC

Guerrini R, Duchowny M, Jayakar P, et al. . Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015;56(11):1669-1686. PubMed

Kwan P, Arzimanoglou A, Berg AT, et al. . Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. PubMed

Blumcke I, Thom M, Aronica E, et al. . The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52(1):158-174. PubMed PMC

Benova B, Sanders MWCB, Uhrova-Meszarosova A, et al. . GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: a possible gradient in severity? Eur J Paediatr Neurol. 2021;30:88-96. PubMed

Galer PD, Ganesan S, Lewis-Smith D, et al. . Semantic similarity analysis reveals robust gene-disease relationships in developmental and epileptic encephalopathies. Am J Hum Genet. 2020;107(4):683-697. PubMed PMC

Richards S, Aziz N, Bale S, et al. , ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. PubMed PMC

Blumcke I, Aronica E, Miyata H, et al. . International recommendation for a comprehensive neuropathologic workup of epilepsy surgery brain tissue: a consensus Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2016;57(3):348-358. PubMed

Najm I, Lal D, Alonso Vanegas M, et al. . The ILAE consensus classification of focal cortical dysplasia: an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2022;63:1899-1919. PubMed PMC

Bienvenu T, des Portes V, Saint Martin A, et al. . Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum Mol Genet. 1998;7(8):1311-1315. PubMed

Strobl-Wildemann G, Kalscheuer VM, Hu H, Wrogemann K, Ropers HH, Tzschach A. Novel GDI1 mutation in a large family with nonsyndromic X-linked intellectual disability. Am J Med Genet A. 2011;155a(12):3067-3070. PubMed

des Portes V, Billuart P, Carrié A, et al. . A gene for dominant nonspecific X-linked mental retardation is located in Xq28. Am J Hum Genet. 1997;60(4):903-909. PubMed PMC

D'Adamo P, Menegon A, Lo Nigro C, et al. . Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet. 1998;19(2):134-139. PubMed

Tran Mau-Them F, Guibaud L, Duplomb L, et al. . De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Genet Med. 2019;21(4):1008-1014. PubMed

Marcogliese PC, Shashi V, Spillmann RC, et al. . IRF2BPL is associated with neurological phenotypes. Am J Hum Genet. 2018;103(2):456-460. PubMed PMC

Beck DB, Petracovici A, He C, et al. . Delineation of a human mendelian disorder of the DNA demethylation machinery: TET3 deficiency. Am J Hum Genet. 2020;106(2):234-245. PubMed PMC

Hiraide T, Hattori A, Ieda D, et al. . De novo variants in SETD1B cause intellectual disability, autism spectrum disorder, and epilepsy with myoclonic absences. Epilepsia Open. 2019;4(3):476-481. PubMed PMC

Roston A, Evans D, Gill H, et al. . SETD1B-associated neurodevelopmental disorder. J Med Genet. 2021;58(3):196-204. PubMed

Helbig I, Lopez-Hernandez T, Shor O, et al. . A recurrent missense variant in AP2M1 impairs clathrin-mediated endocytosis and causes developmental and epileptic encephalopathy. Am J Hum Genet. 2019;104(6):1060-1072. PubMed PMC

Vetro A, Nielsen HN, Holm R, et al. . ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. Brain. 2021;144:1435-1450. PubMed

Monteiro FP, Curry CJ, Hevner R, et al. . Biallelic loss of function variants in ATP1A2 cause hydrops fetalis, microcephaly, arthrogryposis and extensive cortical malformations. Eur J Med Genet. 2020;63(1):103624. PubMed

Chatron N, Cabet S, Alix E, et al. . A novel lethal recognizable polymicrogyric syndrome caused by ATP1A2 homozygous truncating variants. Brain. 2019;142(11):3367-3374. PubMed

Bianchi V, Farisello P, Baldelli P, et al. . Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training. Hum Mol Genet. 2009;18(1):105-117. PubMed PMC

French JA, Lawson JA, Yapici Z, et al. . Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153-2163. PubMed

Vawter-Lee M, Franz DN, Fuller CE, Greiner HM. Clinical Letter: a case report of targeted therapy with sirolimus for NPRL3 epilepsy. Seizure. 2019;73:43-45. PubMed

Lai D, Gade M, Yang E, et al. . Somatic variants in diverse genes leads to a spectrum of focal cortical malformations. Brain. 2022;145:2704-2720. PubMed PMC

Baldassari S, Ribierre T, Marsan E, et al. . Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathologica. 2019;138(6):885-900. PubMed PMC

Cellini E, Vetro A, Conti V, et al. . Multiple genomic copy number variants associated with periventricular nodular heterotopia indicate extreme genetic heterogeneity. Eur J Hum Genet EJHG. 2019;27(6):909-918. PubMed PMC

Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 2014;13(7):710-726. PubMed PMC

Kim S, Baldassari S, Sim NS, et al. . Detection of brain somatic mutations in CSF from refractory epilepsy patients. Ann Neurol. 2021;89(6):1248-1252. PubMed

A new perspective on drug-resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome

COL4A1 mutation-related disorder presenting as fetal intracranial bleeding, hydrocephalus, and polymicrogyria